Core Viewpoint - Shuttle Pharmaceuticals Holdings, Inc. has appointed George Scorsis as the Chairman of the Board of Directors, bringing extensive experience in leading companies in regulated industries to rapid growth [1][2]. Company Overview - Shuttle Pharmaceuticals is a discovery and development stage specialty pharmaceutical company focused on enhancing outcomes for cancer patients undergoing radiation therapy (RT) [4]. - The company's mission is to develop therapies that maximize the effectiveness of RT while minimizing side effects, aiming to increase cancer cure rates, prolong patient survival, and improve quality of life [4]. Leadership Experience - George Scorsis has over 25 years of experience in various industries, including alcohol, energy drinks, and biotech, with notable positions such as President at Mettrum Health Corp. and CEO of Liberty Health Sciences [2]. - He currently holds chairmanship roles at Entourage Health Corp. and AWAKN Life Sciences, both publicly traded [2]. Strategic Vision - Scorsis expressed his commitment to leveraging the company's radiation sensitizers to improve cancer treatment outcomes, particularly for glioblastoma patients, aiming to enhance cure rates and patient quality of life [3].
Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors